Judge Tosses Boehringer Bid to Block Biden Drug Price Plan

Boehringer Ingelheim’s attempt to block the Medicare Drug Price Negotiation Program was rejected by a federal judge Wednesday, handing another win to the Biden administration in the war of lawsuits challenging his signature health plan.

Chief Judge Michael P. Shea of the US District Court for the District of Connecticut denied all of Boehringer Ingelheim Pharmaceuitcals Inc.'s claims that the Biden administration’s program is unconstitutional.

At issue is whether the signature Inflation Reduction Act plan to lower the costs of the prescription drugs Medicare spends the most on is unconstitutional by forcing the company to agree to a maximum fair ...